Trials are underway to assess whether common blood pressure medication can delay the progression of dementia and Alzheimer’s disease
20 March, 2014
Their clinical and translational research program has developed Dbait molecules now in Phase I clinical trial in patients with advanced melanoma. Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and DNA Therapeutics, a biopharmaceutical company that is developing a new class of cancer drugs, are renewing their partnership.
08 March, 2014